HRSA: Request for Information: 340B Rebate Model Pilot Program
Source
Federal Register
Link
Date
Feb 17, 2026
Summary
The Health Resources and Services Administration (HRSA) is seeking comments on a request for information (RFI) regarding the potential use of rebates to effectuate the ceiling price under the 340B Program. The information collected through this RFI will be used to evaluate the potential benefits and costs of a rebate model, and such a model's operational, financial, and access to drugs for patients of a rebate model on covered entities, manufacturers, and other stakeholders. Comments are due by March 19, 2026.
Tagged as
Access
· Healthcare business and finance
· Pharmacy and prescription drugs
· Policy
· Reimbursement and payment models
